We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

New Biomarker Distinguishes Early-stage Multiple Sclerosis From Similar Disorders

News   Apr 27, 2020 | Original story from FAPESP

 
New Biomarker Distinguishes Early-stage Multiple Sclerosis From Similar Disorders

Diagnostic strategy developed by Brazilian researchers can also be used to distinguish MS from neuromyelitis optica, another demyelinating disorder. The two diseases have similar symptoms but must be treated differently Credit: UFSCar

 
 
Advertisement
 

RELATED ARTICLES

Marine Molecules With Therapeutic Potential Against Alzheimer's Disease

News

A study has discovered two potential candidates to treat Alzheimer’s disease. The two marine molecules, meridianine and lignarenone B, can alter the activity of GSK3B activity, a protein linked to several neurodegenerative diseases.

READ MORE

Could Sugars Be the Key to a “Better” Test for Prostate Cancer

News

A new type of test that uses complex sugars to detect prostate cancer, earlier and more accurately, is being developed by researchers at the University of Birmingham.

READ MORE

New Evidence for a Blood-based Biomarker for Alzheimer's Disease

News

A potential blood-based biomarker for Alzheimer's and other neurodegenerative diseases seems even more promising thanks to new research from a Massachusetts General Hospital-led study.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Diagnostics Neuroscience

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE